Stay updated on Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page
- Check6 days agoChange DetectedGlossary functionality is now available and update-tracking labels have been refreshed to include Last Update Submitted that Met QC Criteria and Last Update Posted, along with Revision: v3.4.0. Older labels and data fields such as Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 have been removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s revision history shows an added Revision: v3.3.4 and a removal of Revision: v3.3.3. This is a minor housekeeping update with no impact on study content or user-facing functionality.SummaryDifference0.0%

- Check42 days agoChange DetectedDifference3%

- Check71 days agoChange DetectedThe page now includes a note that PubMed-pulled publications may not all pertain to the study, and the Revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedThe government funding status notice was removed from the page, with no evident changes to trial details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedNo additions or deletions were observed on the page; the study details content remains unchanged.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.